10-Q//Quarterly update
AEOLUS PHARMACEUTICALS, INC. 10-Q
Accession 0001261734-08-000007
CIK 0001261734operating
Filed
Feb 5, 7:00 PM ET
Accepted
Feb 6, 3:16 PM ET
Size
391.2 KB
Accession
0001261734-08-000007
Documents
- 10-Qform10q1stqtr08.htmPrimary
FORM 10-Q FOR THE QUARTER ENDED DECEMBER 31, 2007
- EX-31.1ex3111stqtr08.htm
CERTIFICATION OF THE CHIEF EXECUTIVE OFFICER PURSUANT TO EXCHANGE ACT RULES 13A-14(A) AND 15D-14(A)
- EX-31.2ex3121stqtr08.htm
CERTIFICATION OF THE CHIEF FINANCIAL OFFICER PURSUANT TO EXCHANGE ACT RULES 13A-14(A) AND 15D-14(A)
- EX-32.1ex3211stqtr08.htm
CERTIFICATION BY THE CHIEF EXECUTIVE OFFICER AND CHIEF FINANCIAL OFFICER PURSUANT TO 18 U.S.C. 1350 AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
Issuer
AEOLUS PHARMACEUTICALS, INC.
CIK 0001261734
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001261734
Filing Metadata
- Form type
- 10-Q
- Filed
- Feb 5, 7:00 PM ET
- Accepted
- Feb 6, 3:16 PM ET
- Size
- 391.2 KB